Series B - SAB Biotherapeutics - Jul 17, 2020 Funding Round Profile - Cointime

Bitcoin $93,872.29 -0.40%
Ethereum $3,357.04 -0.98%
BNB $702.96 -0.58%
Optimism $1.79 -3.80%
Arbitrum $0.73 -2.62%
Solana $194.27 -0.18%
Polygon $0.46 -2.98%
Cosmos $6.29 -2.04%
Avalanche $35.89 -2.63%

Bitcoin $93,872.29 -0.40%
Ethereum $3,357.04 -0.98%
BNB $702.96 -0.58%
Optimism $1.79 -3.80%
Arbitrum $0.73 -2.62%
Solana $194.27 -0.18%
Polygon $0.46 -2.98%
Cosmos $6.29 -2.04%
Avalanche $35.89 -2.63%

SAB Biotherapeutics

company

Funding Round

Series B

Money Raised

$ 14M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 7, 2016	Grant	$ 1.42M	National Institutes of Health	Detail